Bank Of New York Mellon Corp Solid Biosciences Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.43 - $1.24 $63,440 - $182,945	-147,537 Reduced 76.29%	45,856 $28,000
Q1 2022 May 11, 2022	SELL	$0.74 - $1.79 $3,649 - $8,828	-4,932 Reduced 2.49%	193,393 $232,000
Q4 2021 Feb 11, 2022	BUY	$1.69 - $2.46 $669 - $974	396 Added 0.2%	198,325 $347,000
Q3 2021 Nov 12, 2021	BUY	$2.38 - $3.77 $81,505 - $129,107	34,246 Added 20.92%	197,929 $473,000
Q2 2021 Aug 11, 2021	BUY	$3.49 - $5.51 $247,646 - $390,984	70,959 Added 76.53%	163,683 $599,000
Q1 2021 May 13, 2021	SELL	$5.37 - $10.72 $46,692 - $93,210	-8,695 Reduced 8.57%	92,724 $512,000
Q4 2020 Feb 09, 2021	BUY	$3.08 - $7.79 $68,865 - $174,176	22,359 Added 28.28%	101,419 $768,000
Q3 2020 Nov 12, 2020	BUY	$2.02 - $3.08 $1,001 - $1,527	496 Added 0.63%	79,060 $160,000
Q2 2020 Aug 12, 2020	SELL	$2.1 - $3.42 $10,413 - $16,959	-4,959 Reduced 5.94%	78,564 $230,000
Q1 2020 May 06, 2020	BUY	$2.31 - $4.43 $24,289 - $46,581	10,515 Added 14.4%	83,523 $199,000
Q4 2019 Feb 14, 2020	BUY	$2.82 - $12.9 $10,501 - $48,039	3,724 Added 5.37%	73,008 $324,000
Q3 2019 Nov 07, 2019	SELL	$4.33 - $11.64 $8,499 - $22,849	-1,963 Reduced 2.76%	69,284 $716,000
Q2 2019 Aug 12, 2019	BUY	$4.6 - $10.13 $87,758 - $193,260	19,078 Added 36.57%	71,247 $410,000
Q1 2019 May 14, 2019	SELL	$7.19 - $32.37 $32,599 - $146,765	-4,534 Reduced 8.0%	52,169 $480,000
Q4 2018 Feb 11, 2019	BUY	$21.32 - $46.34 $318,201 - $691,624	14,925 Added 35.72%	56,703 $1.52 Million
Q3 2018 Nov 09, 2018	BUY	$36.35 - $51.7 $359,465 - $511,261	9,889 Added 31.01%	41,778 $0
Q2 2018 Aug 06, 2018	BUY	$7.33 - $43.15 $85,951 - $505,976	11,726 Added 58.16%	31,889 $1.14 Million
Q1 2018 May 15, 2018	BUY	$7.19 - $33.17 $144,971 - $668,806	20,163 New	20,163 $152,000

Others Institutions Holding SLDB

# of Institutions

Shares Held

Call Options Held

Put Options Held

View Full List

About Solid Biosciences Inc.

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $22.7M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

More about SLDB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account